|
| |
Cathepsin BCathepsin B, also known as CTSB, is a human gene. (From the Wikpedia article Cathepsin B.) Download PDF containing detailed information.
Recent Publications on Cathepsin B: |  |
Cathepsin L inactivates human trypsinogen whereas cathepsin L-deletion reduces the severity of pancreatitis in mice.
BACKGROUND & AIMS:: Acute pancreatitis is characterized by an activation... | 11th November, 2009
| Division of Experimental Surgery, Department of Surgery,
| Gastroenterology. 2009 Nov 6.
DOI Direct Link |
Lipid peroxidation products reduce lysosomal protease activities in human retinal pigment epithelial cells via two different mechanisms of action.
In age-related macular degeneration (AMD), reduced lysosomal capacity may... | 10th November, 2009
| Department of Ophthalmology, University of Bonn, Bonn, Germany.
| Exp Eye Res. 2009 Nov 3.
DOI Direct Link |
Septoclast Deficiency Accompanies Postnatal Growth Plate Chondrodysplasia in the Toothless (tl) Osteopetrotic, Colony-Stimulating Factor-1 (CSF-1)-Deficient Rat and Is Partially Responsive to CSF-1 Injections.
The septoclast is a specialized, cathepsin B-rich, perivascular cell type... | 7th November, 2009
| From the Departments of Cell Biology* and Orthopedics, University of
| Am J Pathol. 2009 Nov 5.
DOI Direct Link |
Increased Activity and Altered Subcellular Distribution of Lysosomal Enzymes Determine Neuronal Vulnerability in Niemann-Pick Type C1-Deficient Mice.
Niemann-Pick disease type C (NPC), caused by mutations in the Npc1 or Npc2... | 7th November, 2009
| From the Departments of Psychiatry* and Medicine, Centre for Prions and
| Am J Pathol. 2009 Nov 5.
DOI Direct Link |
The effect of new proteasome inhibitors, belactosin A and C, on protein metabolism in isolated rat skeletal muscle.
The proteasome inhibitors are used as research tools to study of the... | 6th November, 2009
| Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles
| J Physiol Biochem. 2009 Jun;65(2):137-46.
|
→View more research publications. |
Press Releases About Cathepsin B:
|
 |
| VisEn Launches New Cat B 750 Fast(TM) Fluorescence Molecular Imaging Agent at American Heart Association Meeting |
12th November, 2009 |
VisEn Medical Inc. |
ORLANDO, Fla., Nov. 12 /PRNewswire/ -- VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new Cat B 750 FAST(TM)
|
| VisEn Launches New Cat-K FAST(TM) Fluorescence Molecular Imaging Agent |
7th July, 2009 |
VisEn Medical Inc. |
BEDFORD, Mass., July 7 /PRNewswire/ -- VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new Cat-K FAST(TM)
|
BioPortfolio Ltd. offers e-mail and postal lists for Cathepsin B scientists - we have details of around 344 individuals working on Cathepsin B .
This page has been viewed 344 times
Recent Search Terms used to find this page: what is cathepsin | what is cathepsin | CATHEPSIN B CLINICAL | what is cathepsin | Cathepsin clinical | what is cathepsin | what is cathepsin | cathepsin B clinical development | cathepsin clinical trials | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Cathepsin B across BioPortfolio, or for Cathepsin B Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
